Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

11 COVID-19 therapies you need to know

By Brian Buntz | December 22, 2020

7. AstraZeneca aims to vaccinate much of the world with AZD1222

Developer: AstraZeneca (LON:AZN) and Oxford University

Description: AstraZeneca’s vaccine is less expensive than those from COVID-19 vaccine frontrunners Moderna and Pfizer/BioNTech, but the efficacy of ChAdOx1 nCoV-19 vaccine (AZD1222) is also lower. With an average efficacy of 70%, AZD1222 trails the mRNA vaccines from rivals by approximately 25%. For participants who received half of the initial dose of the two-dose vaccine, however, efficacy was 90%.

The Oxford-AstraZeneca vaccine was 62% effective when administered in two full doses, according to an interim analysis of a Phase 3 trial. Image courtesy of Oxford University.

In September, AstraZeneca announced that it was voluntarily pausing the Phase 3 trial so an independent committee could review safety data surrounding a single event of an unexplained illness that occurred in the U.K.

Development status: AstraZeneca has released interim results from its Phase 3 trial and published them in the Lancet.

The company says it can produce up to 3 billion vaccine doses in 2021.

AstraZeneca is partnering with the Gamaleya Research Institute, the developers of the Russian vaccine Sputnik V, to test a combination of vaccines to inoculate against SARS-CoV-2.

Next>>

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

Tell Us What You Think! Cancel reply

Related Articles Read More >

Norway investigating deaths of 23 individuals who received COVID-19 vaccine
Pharma image
Here’s what molecular shape can tell you about pharma innovation
Remdesivir
3 notable types of innovative drugs from 2020
Phastar
Phastar wins investment from Charterhouse Capital Partners

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards